Effective GH Replacement with Once-weekly Somapacitan in Japanese Children with GH Deficiency: 2-year Results from REAL4

被引：0
|
作者：
Ohata, Yasuhisa [1 ]
Mori, Jun [2 ]
Fujisawa, Yasuko [3 ]
Sato, Yukihito [4 ]
Rohrich, Sebastian [5 ]
Rasmussen, Michael Hojby [6 ]
Bang, Rikke Beck [7 ]
Horikawa, Reiko [8 ]
机构：
[1] Osaka Univ, Dept Pediat, Grad Sch Med, Suita, Osaka, Japan
[2] Osaka City Gen Hosp, Div Pediat Endocrinol & Metab, Childrens Med Ctr, Osaka, Japan
[3] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4, Japan
[4] Novo Nordisk Pharma Ltd, Tokyo, Japan
[5] Novo Nordisk AS, Zurich, Switzerland
[6] Novo Nordisk AS, Clin Drug Dev, Soborg, Denmark
[7] Novo Nordisk AS, Aalborg, Denmark
[8] Natl Ctr Child Hlth & Dev, Div Endocrinol & Metab, Tokyo, Japan
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2023年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FC11.5
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [31] Clinical and radiographic results from a 2-year comparison of once-weekly versus twice-weekly administration of etanercept in biologics-naive patients with rheumatoid arthritis
    Wada, Takahiko
    Son, Yonsu
    Ozaki, Yoshiro
    Nomura, Shosaku
    Iida, Hirokazu
    MODERN RHEUMATOLOGY, 2012, 22 (06) : 824 - 830
  • [32] Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study
    Boonen, Steven
    Orwoll, Eric S.
    Wenderoth, Dietrich
    Stoner, Karen J.
    Eusebio, Rachelle
    Delmas, Pierre D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (04) : 719 - 725
  • [33] Long-term Safety of a once-weekly Somatrogon (hGH-CTP): 4-Year Results: of a Phase 2 Extension Study in Children with Growth Hormone Deficiency
    Zielinska, Nataliya
    Skorodok, Yulia
    Malievsky, Oleg
    Iotova, Violeta
    Rosenfeld, Ron G.
    Zadik, Zvi
    Vander, Shelly
    Pastrak, Aleksandra
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 309 - 309
  • [34] Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study
    Horikawa, Reiko
    Tanaka, Toshiaki
    Hasegawa, Yukihiro
    Yorifuji, Tohru
    Ng, David
    Rosenfeld, Ron G.
    Hoshino, Yuko
    Okayama, Akifumi
    Shima, Daisuke
    Gomez, Roy
    Pastrak, Aleksandra
    Castellanos, Orlando
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (03): : 275 - 285
  • [35] Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial
    Otsuka, Fumio
    Rasmussen, Michael Hojby
    Endo, Takaaki
    Svaerke, Claus
    Tahara, Shigeyuki
    Johannsson, Gudmundur
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [36] Real-world use of once-weekly semaglutide in type 2 diabetes: Results from the SURE UK study
    Holmes, P.
    Catarig, A. M.
    Clark, A.
    Erhan, U.
    Sathyapalan, T.
    DIABETIC MEDICINE, 2021, 38
  • [37] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany
    Menzen, Markus
    Berentzen, Tina Landsvig
    Catarig, Andrei-Mircea
    Pieperhoff, Sebastian
    Simon, Joerg
    Jacob, Stephan
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2023, 131 (04) : 205 - 215
  • [38] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
    Holmes, Patrick
    Bell, Heather Elizabeth
    Bozkurt, Karan
    Catarig, Andrei-Mircea
    Clark, Alice
    Machell, Alena
    Sathyapalan, Thozhukat
    DIABETES THERAPY, 2021, 12 (11) : 2891 - 2905
  • [39] Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from the SURE UK Multicentre, Prospective, Observational Study
    Patrick Holmes
    Heather Elizabeth Bell
    Karan Bozkurt
    Andrei-Mircea Catarig
    Alice Clark
    Alena Machell
    Thozhukat Sathyapalan
    Diabetes Therapy, 2021, 12 : 2891 - 2905
  • [40] Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial
    Inoue, Megumi
    Shiramoto, Masanari
    Oura, Tomonori
    Nasu, Risa
    Nakano, Masako
    Takeuchi, Masakazu
    DIABETES THERAPY, 2019, 10 (03) : 1019 - 1027
12345